FULL DETAILS (Read-only)  -> Click Here to Create PDF for Current Dataset of Trial
CTRI Number  CTRI/2025/07/091740 [Registered on: 25/07/2025] Trial Registered Prospectively
Last Modified On: 09/03/2026
Post Graduate Thesis  Yes 
Type of Trial  Interventional 
Type of Study   Ayurveda 
Study Design  Randomized, Parallel Group, Active Controlled Trial 
Public Title of Study   A study comparing two ayurvedic medicines for fatty lumps under the skin 
Scientific Title of Study   A Comparative clinical study of Navak guggulu and Shakhotak Kwath in Medoja Granthi (Lipoma) 
Trial Acronym  NIL 
Secondary IDs if Any  
Secondary ID  Identifier 
NIL  NIL 
 
Details of Principal Investigator or overall Trial Coordinator (multi-center study)  
Name  Sonali  
Designation  Pg scholar  
Affiliation  PATANJALI BHARTIYA AYURVIGYAN EVAM ANUSANDHAN SANSTHAN, HARIDWAR 
Address  PG DEPARTMENT OF SHALYA TANTRA ,OPD NO-15 PATANJALI BHARTIYA AYURVIGYAN EVAM ANUSANDHAN SANSTHAN, HARIDWAR
PG DEPARTMENT OF SHALYA TANTRA ,OPD NO-15 PATANJALI BHARTIYA AYURVIGYAN EVAM ANUSANDHAN SANSTHAN, HARIDWAR
Hardwar
UTTARANCHAL
249405
India 
Phone  8191030497  
Fax    
Email  sonalibhatt93330@gmail.com  
 
Details of Contact Person
Scientific Query
 
Name  DR SACHIN GUPTA 
Designation  PROFESSOR  
Affiliation  PATANJALI BHARTIYA AYURVIGYAN EVAM ANUSANDHAN SANSTHAN  
Address  SHALYA TANTRA DEPATMENT ,OPD NO-15,PATANJALI BHARTIYA AYURVIGYAN EVAM ANUSANDHAN SANSTHAN ,HARIDWAR
SHALYA TANTRA DEPATMENT ,OPD NO-15,PATANJALI BHARTIYA AYURVIGYAN EVAM ANUSANDHAN SANSTHAN ,HARIDWAR
Hardwar
UTTARANCHAL
249404
India 
Phone  9419135050  
Fax    
Email  chintu.925@gmail.com  
 
Details of Contact Person
Public Query
 
Name  Sonali  
Designation  Pg scholar  
Affiliation  PATANJALI BHARTIYA AYURVIGYAN EVAM ANUSANDHAN SANSTHAN  
Address  PG DEPARTMENT OF SHALYA TANTRA ,OPD NO-15 PATANJALI BHARTIYA AYURVIGYAN EVAM ANUSANDHAN SANSTHAN, HARIDWAR
PG DEPARTMENT OF SHALYA TANTRA ,OPD NO-15 PATANJALI BHARTIYA AYURVIGYAN EVAM ANUSANDHAN SANSTHAN, HARIDWAR
Hardwar
UTTARANCHAL
249405
India 
Phone  8191030497  
Fax    
Email  sonalibhatt93330@gmail.com  
 
Source of Monetary or Material Support  
PATANJALI AYURVEDIC HOSPITAL HARIDWAR  
 
Primary Sponsor  
Name  PATANJALI AYURVEDIC COLLEGE,HARIDWAR  
Address  PATANJALI BHARTIYA AYURVIGYAN EVAM ANUSANDHAN SANSTHAN, HARIDWAR 
Type of Sponsor  Private medical college 
 
Details of Secondary Sponsor  
Name  Address 
Nil  Nil 
 
Countries of Recruitment     India  
Sites of Study  
No of Sites = 1  
Name of Principal Investigator  Name of Site  Site Address  Phone/Fax/Email 
Dr Sonali MD first year  PATANJALI BHARTIYA AYURVIGYAN EVAM ANUSANDHAN SANSTHAN, HARIDWAR  OPD NO. 15 SHALYA TANTRA , PATANJALI BHARTIYA AYURVIGYAN EVAM ANUSANDHAN SANSTHAN, HARIDWAR
Hardwar
UTTARANCHAL 
8191030497

sonalibhatt93330@gmail.com 
 
Details of Ethics Committee  
No of Ethics Committees= 1  
Name of Committee  Approval Status 
INSTITUTIONAL ETHICAL COMMITTEE,PATANJALI AYURVEDIC COLLEGE ,HARIDWAR  Approved 
 
Regulatory Clearance Status from DCGI  
Status 
Not Applicable 
 
Health Condition / Problems Studied  
Health Type  Condition 
Patients  (1) ICD-10 Condition:D173||Benign lipomatous neoplasm of skinand subcutaneous tissue of other and unspecified sites. Ayurveda Condition: MEDOJAGRANTHIH,  
 
Intervention / Comparator Agent  
snoIntervention/ComparatorTypeDrug-TypeProcedure NameDetails
1Intervention ArmDrugClassical(1) Medicine Name: shakhotak kwath, Reference: Sharangdhar samhita, Route: Oral, Dosage Form: Kwatha/ Kashaya, Dose: 20(ml), Frequency: bd, Bhaishajya Kal: Abhakta, Duration: 3 Months, anupAna/sahapAna: No, Additional Information: -
2Intervention ArmDrugClassical(1) Medicine Name: shakhotak kwath, Reference: Sharangdhar samhita , Route: Oral, Dosage Form: Kwatha/ Kashaya, Dose: 20(ml), Frequency: bd, Bhaishajya Kal: Abhakta, Duration: 3 Months, anupAna/sahapAna: Yes(details: -luke warm water), Additional Information: -
 
Inclusion Criteria  
Age From  18.00 Year(s)
Age To  70.00 Year(s)
Gender  Both 
Details  patient willing for the consent.
patient of age between 18 to 70 years of both sexes.
patient having lipoma anywhere on the body. 
 
ExclusionCriteria 
Details  patient having lipoma with inflammation and hyperpigmentation.
Infected lipoma.
Calcified lipoma.
Ulcerated lipoma.
malignant changes in liopma[liposarcoma]
pregnant women and lactating mothers.
 
 
Method of Generating Random Sequence   Adaptive randomization, such as minimization 
Method of Concealment   An Open list of random numbers 
Blinding/Masking   Open Label 
Primary Outcome  
Outcome  TimePoints 
SUBJECTIVE PARAMETER-
PAIN SITE 
30 DAYS 
 
Secondary Outcome  
Outcome  TimePoints 
OBJECTIVE PARAMETER-
SIZE,NO. . 
30 DAYS 
 
Target Sample Size   Total Sample Size="60"
Sample Size from India="60" 
Final Enrollment numbers achieved (Total)= "Applicable only for Completed/Terminated trials"
Final Enrollment numbers achieved (India)="Applicable only for Completed/Terminated trials" 
Phase of Trial   Phase 2 
Date of First Enrollment (India)   06/08/2025 
Date of Study Completion (India) Applicable only for Completed/Terminated trials 
Date of First Enrollment (Global)  Date Missing 
Date of Study Completion (Global) Applicable only for Completed/Terminated trials 
Estimated Duration of Trial   Years="1"
Months="6"
Days="0" 
Recruitment Status of Trial (Global)
Modification(s)  
Not Yet Recruiting 
Recruitment Status of Trial (India)  Open to Recruitment 
Publication Details   N/A 
Individual Participant Data (IPD) Sharing Statement

Will individual participant data (IPD) be shared publicly (including data dictionaries)?  

Response - YES
  1. What data in particular will be shared?
    Response - All of the individual participant data collected during the trial, after de-identification.

  2. What additional supporting information will be shared?
    Response -  Study Protocol
    Response -  Statistical Analysis Plan
    Response - Informed Consent Form
    Response - Clinical Study Report

  3. Who will be able to view these files?
    Response - Anyone

  4. For what types of analyses will this data be available?
    Response - Any purpose.

  5. By what mechanism will data be made available?
    Response - Proposals should be directed to [sonalibhatt93330@gmail.com].

  6. For how long will this data be available start date provided 02-01-1970 and end date provided 02-01-1970?
    Response - Immediately following publication. No end date.

  7. Any URL or additional information regarding plan/policy for sharing IPD? 
    Additional Information - NIL
Brief Summary   IN THIS TRIAL WE ARE SELECTING PATIENTS OF MEDOJ GRANTHI[LIPOMA] AND DIVIDED IN TWO GROUPS [30 PATIENTS IN EACH GROUP].IN 1ST GROUP WE WILL DO INTERVENTION WITH NAVAK GUGGULU .IN 2ND GROUP WE WILL DO INTERVENTION WITH SHAKHOTAK KWATH.  COMPERATIVE STUDY TO BE DONE ON THE BASES OF ASSESSMENT BASED ON SUBJECTIVE AND OBJECTIVE PARAMETERS AND INVESTIGATION DURING PRETREATMENT AS DISSCUSSED EARLIER.   
Close